AXITINIB TABLETS
Glenmark launches generic of Inlyta tablets for kidney cancer treatment in USGlenmark Pharmaceuticals Inc has announced the launch of Axitinib Tablets in the United States in two strengths. These tablets are a generi...
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
This time tailwinds for good and long term: 5 midcap pharma stocks where probably management has learnt the lessonPharma is one sector, where literally every company in the sector has gone through a phase where it is forced to have a look at its own bus...
Glenmark Pharma inks settlement pact with Pfizer for cancer drugThe Mumbai-based drug maker and its US-based unit have inked a settlement pact with drug major Pfizer Inc for Axitinib Tablets (1 mg and 5 ...
Glenmark Pharma gets tentative nod from USFDA for cancer treatment drugGlenmark Pharmaceuticals has received tentative approval by the United States Food & Drug Administration (USFDA) for Axitinib tablets in th...
Load More